Date Filed | Type | Description |
07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/30/2021 |
4/A
| Helsel Dave (SVP Global Operations and R&D) has filed a Form 4 on ANGIODYNAMICS INC
Txns:
| Granted 11,026 options to buy
@ $26.49, valued at
$292.1k
|
|
10/21/2021 |
4
| Helsel Dave (SVP Global Operations and R&D) has filed a Form 4 on ANGIODYNAMICS INC
Txns:
| Sold 3,494 shares
@ $27.97, valued at
$97.7k
|
|
08/18/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/21/2020 |
4
| Helsel Dave (SVP Global Operations and R&D) has filed a Form 4 on ANGIODYNAMICS INC
Txns:
| Paid exercise price by delivering 733 shares
@ $14.29, valued at
$10.5k
|
|
07/21/2020 |
4
| Helsel Dave (SVP Global Operations and R&D) has filed a Form 4 on ANGIODYNAMICS INC
Txns:
| Paid exercise price by delivering 254 shares
@ $9.46, valued at
$2.4k
Paid exercise price by delivering 207 shares
@ $9.21, valued at
$1.9k
Paid exercise price by delivering 155 shares
@ $9.21, valued at
$1.4k
|
|
07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/18/2019 |
4
| Helsel Dave (SVP Global Operations and R&D) has filed a Form 4 on ANGIODYNAMICS INC
Txns:
| Granted 6,945 options to buy
@ $0 |
|
07/25/2019 |
4
| Helsel Dave (SVP Global Operations and R&D) has filed a Form 4 on ANGIODYNAMICS INC
Txns:
| Paid exercise price by delivering 233 shares
@ $21.53, valued at
$5k
Paid exercise price by delivering 172 shares
@ $21.53, valued at
$3.7k
|
|
07/19/2019 |
4
| Helsel Dave (SVP Global Operations and R&D) has filed a Form 4 on ANGIODYNAMICS INC
Txns:
| Granted 3,473 shares
@ $0 Granted 11,615 options to buy
@ $21.54, valued at
$250.2k
|
|
02/01/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/14/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/29/2014 |
4
| Helsel Dave (EVP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Disposed/sold 251 shares
@ $35.92, valued at
$9k
|
|
10/24/2014 |
4
| Helsel Dave (EVP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Granted 3,597 shares
@ $0 Disposed/sold 243 shares
@ $35.44, valued at
$8.6k
Granted 15,964 options to buy
@ $34.745, valued at
$554.7k
Granted 7,194 options to buy
@ $0 |
|
10/24/2014 |
4
| Helsel Dave (EVP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Granted 3,597 shares
@ $0 Disposed/sold 243 shares
@ $35.44, valued at
$8.6k
Granted 15,964 options to buy
@ $34.745, valued at
$554.7k
Granted 7,194 options to buy
@ $0 |
|
04/14/2014 |
4
| Helsel Dave (EVP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Disposed/sold 328 shares
@ $32.48, valued at
$10.7k
|
|
10/29/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/26/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/02/2013 |
4
| Helsel Dave (EVP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Bought 272 shares
@ $32.725, valued at
$8.9k
|
|
04/12/2013 |
4
| Helsel Dave (VP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Disposed/sold 328 shares
@ $41.12, valued at
$13.5k
|
|
11/05/2012 |
4
| Helsel Dave (VP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Bought 144 shares
@ $61.455, valued at
$8.8k
|
|
10/26/2012 |
4
| Helsel Dave (VP, Global Manufacturing) has filed a Form 4 on HAEMONETICS CORP
Txns:
| Granted 1,536 shares
@ $0 Granted 14,307 options to buy
@ $78.11, valued at
$1.1M
|
|
|